Hélène Haegel
![Hélène Haegel Hélène Haegel](https://genetherapy-immunogenicity.com/wp-content/uploads/sites/213/2024/05/Helene-Haegel-150x150.png)
Company: Roche
Job title: Senior Principal Scientist, Immunosafety
Seminars:
HLA-Dependent Risk of T-cell Response to Micro-Dystrophin Transgene Product in Patients with DMD Harboring Mutations in Dystrophin N-terminal Region and Treated with AAV-based Gene Therapies 9:30 am
In silico and ex vivo investigations to understand the SAEs of immune-mediated myositis in DMD clinical trials Assessment of HLA-dependent immunogenicity risks Read more
day: Conference Day Two